Australia approves Pfizer booster for 16–17 year olds

31 January 2022 | Monday | News

Advice from ATAGI is expected to be provided to government shortly
Image Source : Public Domain

Image Source : Public Domain

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people aged 16–17 years old.

The advice from the TGA is the first step of a two-stage process, with further advice, including the timeframe that a booster should be administered after the second dose, to be provided by the Australian Technical Advisory Group on Immunisation (ATAGI).

Australia was one of the first countries in the world to commence a whole of population COVID-19 booster program. Over 7.1 million Australians have already received a booster dose over recent weeks.

Over 93.1 percent of Australians aged 16 and over have completed their primary course of vaccination.

The Australian Government has secured more than 151 million booster doses for delivery over the coming year and is well placed to continue to achieve world leading vaccination rates against COVID-19.

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in